Biomea Fusion
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biomea Fusion and other ETFs, options, and stocks.About BMEA
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
BMEA Key Statistics
Stock Snapshot
As of today, Biomea Fusion(BMEA) shares are valued at $1.50. The company's market cap stands at 108.45M, with a P/E ratio of -0.97.
During the trading session on 2026-05-05, Biomea Fusion(BMEA) shares reached a daily high of $1.56 and a low of $1.46. At a current price of $1.50, the stock is +2.7% higher than the low and still -3.8% under the high.
Trading volume for Biomea Fusion(BMEA) stock has reached 572.6K, versus its average volume of 1.68M.
The stock's 52-week range extends from a low of $0.87 to a high of $3.08.
The stock's 52-week range extends from a low of $0.87 to a high of $3.08.
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.